These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37835407)

  • 1. Genome-Wide Characterization of TAZ Binding Sites in Mammary Epithelial Cells.
    Liu T; Zhou J; Chen Y; Fang J; Liu S; Frangou C; Wang H; Zhang J
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor.
    Valencia-Sama I; Zhao Y; Lai D; Janse van Rensburg HJ; Hao Y; Yang X
    J Biol Chem; 2015 Jul; 290(27):16906-17. PubMed ID: 25995450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAZ enhances mammary cell proliferation in 3D culture through transcriptional regulation of IRS1.
    Janse van Rensburg HJ; Lai D; Azad T; Hao Y; Yang X
    Cell Signal; 2018 Dec; 52():12-22. PubMed ID: 30138697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
    Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
    J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of chemical compound library screening for transcriptional co-activator with PDZ-binding motif inhibitors using GFP-fused transcriptional co-activator with PDZ-binding motif.
    Nagashima S; Maruyama J; Kawano S; Iwasa H; Nakagawa K; Ishigami-Yuasa M; Kagechika H; Nishina H; Hata Y
    Cancer Sci; 2016 Jun; 107(6):791-802. PubMed ID: 27009852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YAP and TAZ are transcriptional co-activators of AP-1 proteins and STAT3 during breast cellular transformation.
    He L; Pratt H; Gao M; Wei F; Weng Z; Struhl K
    Elife; 2021 Aug; 10():. PubMed ID: 34463254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippo-TAZ signaling is the master regulator of the onset of triple-negative basal-like breast cancers.
    Soyama H; Nishio M; Otani J; Sakuma T; Takao S; Hara S; Masuda T; Mimori K; Toyokuni S; Lydon JP; Nakao K; Nishina H; Fukumoto T; Maehama T; Suzuki A
    Proc Natl Acad Sci U S A; 2022 Jul; 119(29):e2123134119. PubMed ID: 35858357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Real-Time PCR to Measure YAP/TAZ Activity in Human Cells.
    Cao X; Zhao B
    Methods Mol Biol; 2019; 1893():137-152. PubMed ID: 30565132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
    Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
    Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMP4 is a novel transcriptional target and mediator of mammary cell migration downstream of the Hippo pathway component TAZ.
    Lai D; Yang X
    Cell Signal; 2013 Aug; 25(8):1720-8. PubMed ID: 23673366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition.
    Zhang H; Liu CY; Zha ZY; Zhao B; Yao J; Zhao S; Xiong Y; Lei QY; Guan KL
    J Biol Chem; 2009 May; 284(20):13355-13362. PubMed ID: 19324877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer.
    Liu CY; Yu T; Huang Y; Cui L; Hong W
    J Biol Chem; 2017 Jun; 292(22):9420-9430. PubMed ID: 28408625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of TAZ domains important for the induction of breast cancer stem cell properties and tumorigenesis.
    Li YW; Shen H; Frangou C; Yang N; Guo J; Xu B; Bshara W; Shepherd L; Zhu Q; Wang J; Hu Q; Liu S; Morrison CD; Sun P; Zhang J
    Cell Cycle; 2015; 14(1):146-56. PubMed ID: 25602524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tead2 expression levels control the subcellular distribution of Yap and Taz, zyxin expression and epithelial-mesenchymal transition.
    Diepenbruck M; Waldmeier L; Ivanek R; Berninger P; Arnold P; van Nimwegen E; Christofori G
    J Cell Sci; 2014 Apr; 127(Pt 7):1523-36. PubMed ID: 24554433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Changes During Human Thyroid Cell Differentiation.
    Ma R; Morshed S; Latif R; Davies TF
    Thyroid; 2020 Nov; 30(11):1666-1675. PubMed ID: 32345138
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular dynamics simulations study of influence of Tyr422Ala mutation on transcriptional enhancer activation domain 4 (TEAD4) and transcription co-activators complexes.
    Niu RJ; Zheng QC; Zhang HX
    J Theor Biol; 2019 Jul; 472():27-35. PubMed ID: 30978352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex.
    Merritt N; Garcia K; Rajendran D; Lin ZY; Zhang X; Mitchell KA; Borcherding N; Fullenkamp C; Chimenti MS; Gingras AC; Harvey KF; Tanas MR
    Elife; 2021 Apr; 10():. PubMed ID: 33913810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAZ facilitates breast tumor growth by promoting an immune-suppressive tumor microenvironment.
    Gershoni A; Hassin O; Nataraj NB; Baruch S; Avioz-Seligman A; Pirona AC; Fellus-Alyagor L; Meir Salame T; Mukherjee S; Mallel G; Yarden Y; Aylon Y; Oren M
    Mol Oncol; 2023 Dec; 17(12):2675-2693. PubMed ID: 37716913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yap/Taz inhibit goblet cell fate to maintain lung epithelial homeostasis.
    Hicks-Berthet J; Ning B; Federico A; Tilston-Lunel A; Matschulat A; Ai X; Lenburg ME; Beane J; Monti S; Varelas X
    Cell Rep; 2021 Jul; 36(2):109347. PubMed ID: 34260916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of
    Goto H; Nishio M; To Y; Oishi T; Miyachi Y; Maehama T; Nishina H; Akiyama H; Mak TW; Makii Y; Saito T; Yasoda A; Tsumaki N; Suzuki A
    Development; 2018 Mar; 145(6):. PubMed ID: 29511023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.